Fourth, we could not assess the association between ADI and known prognostic factors, such as tumor budding, number of lymph nodes, tumor location, microsatellite instability, TILs, mutations (such as BRAF and KRAS), or histological subtypes. This evidence concerns the gene BRAF and neoplasm.